Open Therapeutics Company Profile

08:06 EST 15th November 2018 | BioPortfolio

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global scientific community. The global research community can freely access the biotechnologies and funding to further the development of the biotechnologies at Therapoid™ ( The Company is headquartered in Minneapolis, MN, with laboratory operations in Covington, Kentucky, Cincinnati, OH, Amman, Jordan, and Bangalore, India.

News Articles [1083 Associated News Articles listed on BioPortfolio]

PTC Therapeutics' Drug for Spinal Muscular Atrophy Shows Promise in 2 Trials

PTC Therapeutics announced interim data from Part 1 of its open-label clinical trials, FIREFISH and SUNFISH, of risdiplam for Type 1, 2 and 3 spinal muscular atrophy in collaboration with Genentech.

The Open Patient: Advocating for open access to medical data

In The Open Patient: Healing through sharing, a new documentary from Red Hat Videos, Steven Keating and Liz Salmi share their personal stories about advocating for open medical data.

Open Access With A Vengeance

Here’s something to keep an eye on: eleven of the largest national research funding agencies in Europe have announced a plan to require open-access publication of papers arising from their grant...

Introducing BMJ Open’s new article type: The Communication Article

The editorial team at BMJ Open are pleased to announce a new article type. In this blog, we introduce the communication article, highlight our first published example, and tell you how you can submit ...

TG Therapeutics Announces Phase I Study of Novel BTK inhibitor, TG-1701, in Patients with Relapsed or Refractory B-cell Malignancies is Open for Enrollment

First dose cohort fully enrolled First patient enrolled with relapsed/refractory Mantle Cell Lymphoma achieved Partial Response (PR) to lowest dose being tested NEW YORK, Nov. 13, 2018 (GLOBE N...

Summit Therapeutics Announces PhaseOut DMD Did Not Meet Primary Endpoint

Summit Therapeutics (AIM:SUMM, NASDAQ:SMMT) announces PhaseOut DMD has not met its primary or secondary endpoints after 48 weeks of treatment of ezutromid in patients with Duchenne muscular dystrophy....

5 Ways to Shake Up Your Open Enrollment Strategy This Year

11/14/2018 by Lindsay Jacobs   As temperatures drop and the fall season comes to an end, stress spikes in HR departments all over the country—that’s because it’s open enrollment season. Ope...

Kite to open Netherlands cell therapy manufacturing facility

Kite Therapeutics, a subsidiary of Gilead Sciences, has announced it has leased a facility in the Netherlands to engineer cell...Read More... The post Kite to open Netherlands cell therapy manufacturi...

PubMed Articles [1135 Associated PubMed Articles listed on BioPortfolio]

Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial.

The aim of the study was to report longer term (24-month) outcomes for primary open-angle glaucoma (POAG) patients refractory to medical therapy implanted with a supraciliary microstent (CyPass Micro-...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Open-label Extension Phase of a Chronic Diabetic Foot Ulcer Multicenter, Controlled, Randomized Clinical Trial Using Cryopreserved Placental Membrane.

The results of the single-arm, open-label extension phase of the Grafix (cryopreserved placental membrane; CPM; Osiris Therapeutics, Inc, Columbia, MD) multicenter, blinded, randomized, controlled cli...

Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.

This 4-week open-label observational study describes the effect of introducing a microtablet dose dispenser and adjusting doses based on objective free-living motor symptom monitoring in individuals w...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Clinical Trials [1586 Associated Clinical Trials listed on BioPortfolio]

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1717 Associated Companies listed on BioPortfolio]

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Open Source Initiative (OSI)

Open Source Initiative (OSI) is a non-profit corporation dedicated to managing and promoting the Open Source Definition for the good of the community, specifically through the OSI Certified Open Sourc...

Open Health Tools

Open Health Tools is a nonprofit organization that promotes the availability of open technologies in healthcare worldwide. With over 60 members, OHT is transforming the global mar...

Open eHealth Foundation

Open eHealth Foundation (OeHF), launched at HIMSS 08, uses existing open source projects for developing a platform on which its members and other providers can create open source components that a...

eZ systems

Enterprise Open Source eZ systems is the creator of eZ publish, an Open Source Enterprise Content Management System. With an enterprise Open Source business model, we combine enterprise software with ...

More Information about "Open Therapeutics" on BioPortfolio

We have published hundreds of Open Therapeutics news stories on BioPortfolio along with dozens of Open Therapeutics Clinical Trials and PubMed Articles about Open Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Open Therapeutics Companies in our database. You can also find out about relevant Open Therapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record